+

NIPT Cumulative Prenatal Testing Statistic 2024

By Next Biosciences
19 March 2024

Non-Invasice Prenatal Testing (NIPT) was introduced into clinical practice as a screening test for the most common chromosome abnormalities in 2011 and has since revolutionised prenatal care. Due to its high sensitivity and specificity, NIPT is recommended as a first-tier screening test for all pregnancies by many international societies including American College of Obstetricians and Gynecologists (ACOG) and the International Society for Prenatal Diagnosis (ISPD).

Cord blood: Why this life-saving resource shouldn't be overlooked

By Next Biosciences
01 July 2025

July marks Cord Blood Awareness Month — a time to spotlight the life-saving potential of umbilical cord blood stem cells. Despite South Africa’s high birth rate, cord blood is still often discarded due to a lack of awareness. In this blog, we explore how cord blood can treat over 80 serious conditions, including cerebral palsy and leukaemia, and why banking it is a powerful investment in your family’s future.

The future of reproductive health: empowering South Africans during world infertility awareness month

By Next Biosciences
01 July 2025

June marks World Infertility Awareness Month, a vital time to spotlight the growing challenges around fertility and the urgent need for open, informed conversations. In South Africa, where one in five couples face difficulty conceiving, infertility is more than a personal struggle; it's a pressing public health issue. At Next Biosciences, we’re dedicated to reshaping the fertility journey through cutting-edge genetic testing, expert support, and accessible care. Discover how science and compassion come together to empower individuals and families on their path to parenthood.

NIPT Cumulative Prenatal Testing Statistic 2024

By Next Biosciences
19 March 2024

Non-Invasice Prenatal Testing (NIPT) was introduced into clinical practice as a screening test for the most common chromosome abnormalities in 2011 and has since revolutionised prenatal care. Due to its high sensitivity and specificity, NIPT is recommended as a first-tier screening test for all pregnancies by many international societies including American College of Obstetricians and Gynecologists (ACOG) and the International Society for Prenatal Diagnosis (ISPD).